New treatment for disfiguring skin condition

by Claire Mooney
Researchers see the light over new treatment

Researchers from The University of Manchester and Salford Royal NHS Foundation Trust have tested a new way to treat a disfiguring skin condition.

Telangiectatases are knot-like clusters of blood vessels on the skin which can occur in 30 to 50 per cent of with systemic sclerosis, a potentially serious and incurable auto-immune condition that affects .

Telangiectases tend to occur on the face, neck and upper limbs and can cause psychological issues for patients.

Currently, doctors use to blast the telangiectases and destroy them but this treatment can be painful at the time and result in bruising afterwards so researchers have been looking for an alternative.

Salford Royal is one of only a handful of Trusts in the UK specialising in systemic sclerosis, also known as scleroderma, and Consultant Rheumatologist Ariane Herrick, also Professor of Rheumatology at The University of Manchester's Institute for Inflammation and Repair, is a leading UK expert in the condition.

As part of the Trust's and University's wide range of studies to improve care of scleroderma patients, researchers tested using intense pulsed light (IPL) instead of laser treatment. IPL is often used cosmetically for treating birthmarks and for hair removal.

Their pilot study treated 19 patients with telangiectases, using IPL on one side of the face and laser treatment on the other. They had three treatments over the course of eight weeks before the results were analysed using close-up photographs and specialist imaging.

The research showed that the effects were roughly comparable but IPL had fewer side effects.

Salford Royal Rheumatology researcher Dr Graham Dinsdale, who is also a Research Associate at the University's Institute of Inflammation and Repair, said: "While this was only a small-scale , it does suggest the potential for an alternative, less painful, treatment for telangiectases. We will continue to do all we can to find new and better treatments for patients with , which is a very serious and debilitating condition."

add to favorites email to friend print save as pdf

Related Stories

New study to develop personalised treatments for psoriasis

Nov 06, 2013

A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's ...

Recommended for you

Mali doctor dies of Ebola, taking toll up to seven

55 minutes ago

A doctor in Mali died of Ebola on Thursday after treating an imam who succumbed to the disease, taking the total toll in the west African country up to seven, health authorities said.

Breakthrough in managing yellow fever disease

4 hours ago

Yellow fever is a disease that can result in symptoms ranging from fever to severe liver damage. Found in South America and sub-Saharan Africa, each year the disease results in 200,000 new cases and kills ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.